1. AHRO : Austin Health Research Online

Alexander Dobrovic

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Alexander Dobrovic
Full Name
Dobrovic, Alexander
 
Department
 
ORCID
Twitter
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Musafer, Ashan

Results 1-8 of 8 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
115-Sep-2021Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma.Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study, null; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L
228-Jul-2021Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma.Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Eftekhariyan Ghamsari, Mohammad Reza; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Cancer Study, Australian Ovarian; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L
321-Jun-2021A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification.Goh, Su Kah ; Cox, Daniel R A ; Wong, Boris Ka Leong; Musafer, Ashan; Witkowski, Tom ; Do, Hongdo; Muralidharan, Vijayaragavan ; Dobrovic, Alexander 
49-Jun-2021PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.Parakh, Sagun ; Musafer, Ashan; Paessler, Sabrina; Witkowski, Tom ; Suen, Connie S N Li Wai; Tutuka, Candani S A; Carlino, Matteo S; Menzies, Alexander M; Scolyer, Richard A; Cebon, Jonathan S ; Dobrovic, Alexander ; Long, Georgina V; Klein, Oliver ; Behren, Andreas
53-May-2021Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2).Swisher, Elizabeth M; Kwan, Tanya T; Oza, Amit M; Tinker, Anna V; Ray-Coquard, Isabelle; Oaknin, Ana; Coleman, Robert L; Aghajanian, Carol; Konecny, Gottfried E; O'Malley, David M; Leary, Alexandra; Provencher, Diane; Welch, Stephen; Chen, Lee-May; Wahner Hendrickson, Andrea E; Ma, Ling; Ghatage, Prafull; Kristeleit, Rebecca S; Dorigo, Oliver; Musafer, Ashan; Kaufmann, Scott H; Elvin, Julia A; Lin, Douglas I; Chambers, Setsuko K; Dominy, Erin; Vo, Lan-Thanh; Goble, Sandra; Maloney, Lara; Giordano, Heidi; Harding, Thomas; Dobrovic, Alexander ; Scott, Clare L; Lin, Kevin K; McNeish, Iain A
6May-2019Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.Arulananda, Surein; Do, Hongdo; Rivalland, Gareth; Loh, Zoe ; Musafer, Ashan; Lau, Eddie ; Mitchell, Paul; Dobrovic, Alexander ; John, Thomas 
7Nov-2017Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer.Arulananda, Surein; Do, Hongdo; Musafer, Ashan; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
8Jul-2016Comparison of 3 methodologies for genotyping of small deletion and insertion polymorphismsGoh, Su Kah ; Musafer, Ashan; Witkowski, Tom ; Muralidharan, Vijayaragavan ; Christophi, Christopher ; Do, Hongdo; Dobrovic, Alexander